Invesco Ltd. Fulgent Genetics, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 159,413 shares of FLGT stock, worth $2.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

159,413

Previous 166,728 4.39%

Holding current value

$2.85 Million

Previous $3.27 Million 5.84%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$19.6 - $25.06 $143,374 - $183,313	-7,315 Reduced 4.39%	159,413 $3.46 Million
Q2 2024 Aug 13, 2024	SELL	$19.09 - $22.57 $72,751 - $86,014	-3,811 Reduced 2.23%	166,728 $3.27 Million
Q1 2024 May 14, 2024	SELL	$21.55 - $29.29 $4.29 Million - $5.83 Million	-198,874 Reduced 53.84%	170,539 $3.7 Million
Q4 2023 Feb 12, 2024	BUY	$23.64 - $30.27 $1.34 Million - $1.72 Million	56,786 Added 18.16%	369,413 $10.7 Million
Q3 2023 Nov 13, 2023	BUY	$26.74 - $40.81 $5.02 Million - $7.66 Million	187,717 Added 150.28%	312,627 $8.36 Million
Q2 2023 Aug 11, 2023	SELL	$28.52 - $40.7 $6.87 Million - $9.81 Million	-241,033 Reduced 65.87%	124,910 $4.63 Million
Q1 2023 May 12, 2023	BUY	$29.39 - $36.27 $1.38 Million - $1.7 Million	46,957 Added 14.72%	365,943 $11.4 Million
Q4 2022 Feb 13, 2023	SELL	$29.23 - $40.28 $2.65 Million - $3.66 Million	-90,812 Reduced 22.16%	318,986 $9.5 Million
Q3 2022 Nov 14, 2022	BUY	$37.92 - $63.74 $1.55 Million - $2.61 Million	40,950 Added 11.1%	409,798 $15.6 Million
Q2 2022 Aug 15, 2022	BUY	$47.98 - $62.75 $3.47 Million - $4.54 Million	72,288 Added 24.38%	368,848 $20.1 Million
Q1 2022 May 16, 2022	BUY	$49.85 - $96.11 $1.21 Million - $2.33 Million	24,197 Added 8.88%	296,560 $18.5 Million
Q4 2021 Feb 14, 2022	SELL	$77.3 - $105.0 $519,687 - $705,915	-6,723 Reduced 2.41%	272,363 $27.4 Million
Q3 2021 Nov 15, 2021	SELL	$74.87 - $110.87 $1.51 Million - $2.24 Million	-20,220 Reduced 6.76%	279,086 $25.1 Million
Q2 2021 Aug 17, 2021	SELL	$66.8 - $100.45 $17.6 Million - $26.5 Million	-263,839 Reduced 46.85%	299,306 $27.6 Million
Q1 2021 May 17, 2021	SELL	$59.3 - $183.85 $6.61 Million - $20.5 Million	-111,533 Reduced 16.53%	563,145 $54.4 Million
Q4 2020 Feb 16, 2021	BUY	$31.01 - $52.1 $8.73 Million - $14.7 Million	281,682 Added 71.68%	674,678 $35.2 Million
Q3 2020 Nov 16, 2020	BUY	$15.89 - $50.51 $5.9 Million - $18.7 Million	371,155 Added 1699.35%	392,996 $15.7 Million
Q2 2020 Aug 14, 2020	SELL	$8.89 - $18.28 $120,095 - $246,944	-13,509 Reduced 38.21%	21,841 $349,000
Q1 2020 May 15, 2020	BUY	$6.75 - $19.75 $45,225 - $132,325	6,700 Added 23.39%	35,350 $380,000
Q4 2019 Feb 14, 2020	BUY	$9.29 - $15.82 $147,711 - $251,538	15,900 Added 124.71%	28,650 $369,000
Q3 2019 Nov 14, 2019	BUY	$5.96 - $12.81 $75,990 - $163,327	12,750 New	12,750 $132,000

Others Institutions Holding FLGT

# of Institutions

201

Shares Held

16.1M

Call Options Held

2.04M

Put Options Held

14K

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $541M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account